You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 7, 2025

Patent: 10,786,577


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,786,577
Title:Pharmaceutical composition comprising glutatione disulfide and glutathione disulfide S-oxide
Abstract: Pharmaceutical composition comprising glutathione disulphide or pharmaceutically acceptable organic or inorganic salt thereof and glutathione disulfide S-oxide of the following structure: ##STR00001## or pharmaceutically acceptable organic or inorganic salt thereof for eliminating dose-related toxicity and enhancing the therapeutic activity of a pharmacologically active compound in the treatment of infectious and non-infectious diseases is provided. Typically, the composition comprises glutathione disulfide S-oxide in an amount of 0.01-10% by weight of the total composition, and additionally a metal (Me) in the form of coordination compound(s) containing Me-S-glutathione bond, said metal is selected from the platinum group, typically it is platinum. The amount of d-metal coordination compound administered to a patient can be 10.sup.-3 to 10.sup.-15 mol/kg of body weight. The composition can be used in combination with pharmacologically active compound, which is an anticoagulant, factor Xa inhibitor, antimicrobial or antiviral agents to increase their therapeutic activity and eliminate dose-related toxicity.
Inventor(s): Balazovskij; Mark Borisovich (St. Petersburg, RU), Antonov; Viktor Georgievich (St. Petersburg, RU), Ignatenko; Oleg Aleksandrovich (St. Petersburg, RU)
Assignee: OBSCHESTVO S ORGANICHENNOY OTVETSTVENNOSTJU \"IVA FARM\" (St. Petersburg, RU)
Application Number:16/603,042
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive Analysis of United States Patent 10,786,577: A Deep Dive into Claims and Patent Landscape

Introduction

Understanding the intricacies of a patent, particularly in the context of the U.S. patent system, is crucial for inventors, businesses, and legal professionals. This article provides a comprehensive and critical analysis of the claims and the patent landscape for United States Patent 10,786,577, focusing on key aspects such as patent-eligible subject matter, the patent application process, and competitive intelligence.

Patent-Eligible Subject Matter

To begin, it is essential to understand what constitutes patent-eligible subject matter under Section 101 of the Patent Act (35 U.S.C. ยง101). This section defines four categories of patentable inventions: processes, machines, manufactures, and compositions of matter. However, the Supreme Court has established implicit exceptions, excluding laws of nature, natural phenomena, and abstract ideas from patentability unless they are integrated into a practical application[1].

The Patent Application Process

The journey of a patent from application to issuance involves several critical steps. When filing a patent application, the applicant must ensure that the claims meet the criteria of novelty, nonobviousness, and utility. The patent examiner reviews the application, often citing prior art to determine whether the claims are novel and nonobvious. This process is documented in the patent's file wrapper, which includes all correspondence between the applicant and the patent office, providing valuable insights into the patent's legal status and the arguments made during its prosecution[3].

Determining Inventorship

Inventorship is a vital aspect of patent law, as it determines who is entitled to a patent. The conception of the invention is key; it must be a definite and permanent idea that can be reduced to practice by one with ordinary skill in the field. Collaborative efforts can lead to joint inventorship, but mere reduction to practice or routine experimentation does not qualify someone as an inventor[4].

Patent Claims Analysis

Analyzing the claims of a patent is fundamental to understanding its scope and validity. For a patent like 10,786,577, each claim must be scrutinized to determine if it meets the eligibility criteria under Section 101. The claims must be directed to a patent-eligible concept, and if they involve abstract ideas, they must include an inventive concept that transforms the nature of the claim into a practical application[1].

Abstract Ideas and Practical Applications

Recent guidance from the USPTO, particularly the 2024 update, emphasizes the importance of integrating abstract ideas into practical applications. For AI-related inventions, examples provided by the USPTO illustrate how claims can meet eligibility criteria by demonstrating concrete technological improvements. For instance, an artificial neural network designed to identify anomalies can be patent-eligible if it shows an improvement in computer technology[2].

Claim Construction and Eligibility

The construction of claims is crucial in determining patent eligibility. Claims that merely use abstract ideas without applying them in a specific manner that improves technology are generally not patent-eligible. In contrast, claims that specify real-world applications and provide tangible benefits can meet the eligibility criteria. For example, a claim involving a real-time speech recognition system that enhances the accuracy of voice commands in hands-free environments would be considered patent-eligible due to its practical application[2].

Patent Landscape and Competitive Intelligence

Analyzing the patent landscape is essential for understanding the competitive environment and identifying opportunities for innovation. Patent file wrappers provide valuable insights into the prosecution history of a patent, including arguments made between the applicant and the examiner. This information can help in assessing the strength and potential enforceability of a patent[3].

Prior Art Searches and Citation Analysis

Conducting prior art searches is critical in determining the novelty and nonobviousness of an invention. Patent databases are invaluable resources for finding relevant prior art. Citation analysis can also help gauge the importance of a patent within a technological field by examining how it relates to prior and subsequent innovations[5].

Technology Classification and Patent Family Analysis

Technology classification helps in understanding the broader technological context of a patent. Patent family analysis, which involves analyzing patents filed in multiple countries, can provide insights into the geographical coverage and global strategy of the patent holder[5].

Stakeholder Views and Regulatory Updates

Stakeholder views on patent-eligible subject matter jurisprudence vary, with some arguing that the current framework hinders innovation in emerging technologies like AI and biotechnology. Recent updates from the USPTO, such as the 2024 guidance, aim to clarify and refine the process for determining patent eligibility, particularly for AI-related inventions. These updates incorporate recent case law and provide practical examples to aid in drafting patent-eligible claims[1][2].

Key Takeaways

  • Patent-Eligible Subject Matter: Ensure claims fall within the categories defined by Section 101 and avoid judicially developed exceptions unless integrated into a practical application.
  • Claim Construction: Claims must be directed to a patent-eligible concept and include an inventive concept if involving abstract ideas.
  • Patent Landscape Analysis: Use file wrappers and prior art searches to understand the competitive landscape and assess patent strength.
  • Inventorship: Determine inventorship based on the conception of the invention, ensuring it is a definite and permanent idea.
  • Regulatory Updates: Stay updated with USPTO guidance and recent case law to ensure compliance and clarity in patent eligibility.

FAQs

Q: What are the categories of patentable inventions under Section 101 of the Patent Act?

A: The categories include any new and useful process, machine, manufacture, or composition of matter[1].

Q: How do abstract ideas affect patent eligibility?

A: Abstract ideas are not patentable unless they are integrated into a practical application that transforms the nature of the claim[1].

Q: What is the role of the patent file wrapper in patent analysis?

A: The file wrapper contains all correspondence between the applicant and the patent office, providing insights into the patent's legal status and prosecution history[3].

Q: How is inventorship determined in a patent application?

A: Inventorship is determined based on who conceived the subject matter of at least one claim of the patent, focusing on the conception step rather than the reduction to practice[4].

Q: What is the significance of the 2024 USPTO guidance update on AI patents?

A: The update clarifies the process for determining patent eligibility of AI-related inventions, providing examples and integrating recent case law to promote consistency and clarity[2].

Sources

  1. Congressional Research Service, "Patent-Eligible Subject Matter Reform: An Overview," January 3, 2024.
  2. Mintz, "Understanding the 2024 USPTO Guidance Update on AI Patent," July 25, 2024.
  3. IP Checkups, "Patent file wrappers as a tool for competitive intelligence," February 5, 2023.
  4. Oregon State University, "Determining Inventorship for US Patent Applications."
  5. Evalueserve, "Patent Analysis."

More… ↓

⤷  Subscribe

Details for Patent 10,786,577

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bavarian Nordic A/s RABAVERT rabies vaccine For Injection 103334 October 20, 1997 ⤷  Subscribe 2037-11-17
Sanofi Pasteur Sa IMOVAX RABIES rabies vaccine For Injection 103931 February 04, 2000 ⤷  Subscribe 2037-11-17
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.